Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review

Riccardo Inchingolo1, Alessandro Posa2, Martin Mariappan3

  • 1Interventional Radiology Unit, "F. Miulli" Regional Hospital, Acquaviva delle Fonti 70021, Italy.

Insights

Budd-Chiari syndrome (BCS), a rare condition of blocked hepatic veins, has high mortality if untreated. Transjugular intrahepatic portosystemic shunt (TIPS) offers a safe and effective treatment option for BCS patients.

Area of Science:

  • Hepatology
  • Interventional Radiology
  • Vascular Medicine

Background:

  • Budd-Chiari syndrome (BCS) is a rare condition characterized by hepatic venous outflow obstruction.
  • Untreated BCS carries a high mortality rate, necessitating effective management strategies.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and treatment of BCS.
  • To focus on the techniques and outcomes of transjugular intrahepatic portosystemic shunt (TIPS) for BCS management.

Main Methods:

  • Literature review focusing on BCS pathophysiology, diagnosis, and treatment options.
  • Special emphasis on published data concerning TIPS techniques and outcomes in BCS patients.

Main Results:

  • BCS management involves a step-wise approach, including anticoagulation and interventional radiology.
  • Transjugular intrahepatic portosystemic shunt (TIPS) is a safe and highly effective treatment for BCS.

Conclusions:

  • TIPS should be recommended for BCS patients, including those awaiting liver transplantation.
  • Further research is needed to address unresolved issues in BCS management and TIPS application.

Related Concept Videos

Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
4.4K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
265
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
834
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K